Dix Marie, Belleville Troy, Mishra Anjali, Walters Ryan W, Millner Paul, Jabbar Ali Bin Abdul, Tauseef Abubakar
Creighton University School of Medicine, Omaha, NE, United States.
Creighton University Department of Clinical Research and Public Health, Omaha, NE, United States.
Front Med (Lausanne). 2024 Oct 11;11:1469522. doi: 10.3389/fmed.2024.1469522. eCollection 2024.
Central line-associated bloodstream infections (CLABSI) are prevalent and preventable hospital-acquired infections associated with high morbidity and costs. Disparities based on race, ethnicity, and hospital factors remain underexplored. This study compares cost, length of stay, and mortality for adults with CLABSI by race-ethnicity, hospital location-teaching status, and geographic region in the United States using data from the National Inpatient Sample (NIS) database from 2016 to 2020.
The hospitalization cohort included adults diagnosed with CLABSI, excluding those with primary CLABSI diagnoses, cancer, immunosuppressed states, or neonatal conditions. Primary outcomes were in-hospital mortality, length of stay, and hospital costs, adjusted to mid-year 2020 US dollars. Independent variables included race-ethnicity, hospital location-teaching status, and geographic region. All analyses accounted for NIS sampling design.
From 2016 to 2020, there were approximately 19,835 CLABSI hospitalizations. The overall in-hospital mortality rate was 9.1%, with a median hospital stay of 16.9 days and median cost of $44,810. Hispanic patients experienced significantly higher mortality, longer length of stay, and higher costs compared to non-Hispanic Black and White patients. Urban teaching hospitals had longer stays and higher costs than rural and urban non-teaching hospitals. Regionally, the Northeast and West had higher costs and longer stays than the Midwest and South, but mortality rates did not differ significantly.
This study highlights significant disparities in CLABSI outcomes based on demographic factors. Addressing these disparities is crucial for improving CLABSI management and healthcare equity. Further research should explore the underlying causes of these differences to inform targeted interventions.
中心静脉导管相关血流感染(CLABSI)是常见且可预防的医院获得性感染,会导致高发病率和高昂成本。基于种族、民族和医院因素的差异仍未得到充分研究。本研究利用2016年至2020年美国国家住院样本(NIS)数据库的数据,比较了美国不同种族/民族、医院地点-教学状况和地理区域的CLABSI成年患者的成本、住院时间和死亡率。
住院队列包括被诊断为CLABSI的成年人,排除那些原发性CLABSI诊断、癌症、免疫抑制状态或新生儿疾病患者。主要结局为住院死亡率、住院时间和医院成本,并根据2020年年中美元进行调整。自变量包括种族/民族、医院地点-教学状况和地理区域。所有分析均考虑了NIS抽样设计。
2016年至2020年期间,约有19835例CLABSI住院病例。总体住院死亡率为9.1%,中位住院时间为16.9天,中位成本为44810美元。与非西班牙裔黑人和白人患者相比,西班牙裔患者的死亡率显著更高,住院时间更长,成本更高。城市教学医院的住院时间比农村和城市非教学医院更长,成本更高。在地区方面,东北部和西部的成本和住院时间高于中西部和南部,但死亡率没有显著差异。
本研究突出了基于人口统计学因素的CLABSI结局的显著差异。解决这些差异对于改善CLABSI管理和医疗公平性至关重要。进一步的研究应探索这些差异的潜在原因,以便进行有针对性的干预。